Global Candidiasis Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Candidiasis Market was valued at $18.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 4.3% CAGR, to an estimated market size of $22.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global candidiasis market encompasses the diagnosis, treatment, and management of fungal infections caused by Candida species. The scope includes antifungal therapeutics such as azoles, echinocandins, and polyenes, as well as diagnostic testing solutions (molecular, culture-based, and antigen detection). It covers various clinical manifestations including vulvovaginal candidiasis, oropharyngeal candidiasis (oral thrush), and life-threatening invasive candidiasis.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Candidiasis Market in the period 2025-30:
- The rising population of immunocompromised patients, including those with HIV/AIDS, cancer, and organ transplants, is a primary driver for infection rates.
- The emergence of multidrug-resistant strains, specifically Candida auris, is necessitating the development of next-generation antifungal agents.
- There is a significant shift toward molecular diagnostics and PCR-based assays to replace traditional culture methods for faster treatment initiation.
- Increased demand for oral administration and single-dose regimens is improving patient adherence in outpatient settings.
- The market is seeing a focus on novel drug classes such as echinocandins and non-azole therapies like ibrexafungerp to combat resistance.
- Expanding healthcare infrastructure and rising awareness in the Asia-Pacific region are driving the highest regional growth rates.
- High mortality rates associated with candidemia in intensive care units continue to drive the high-value hospital pharmacy segment.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Vaginal Candidiasis
- Invasive Candidiasis
- Oral Thrush
- Other Indications